Main Page
Deanship
The Dean
Dean's Word
Curriculum Vitae
Contact the Dean
Vision and Mission
Organizational Structure
Vice- Deanship
Vice- Dean
KAU Graduate Studies
Research Services & Courses
Research Services Unit
Important Research for Society
Deanship's Services
FAQs
Research
Staff Directory
Files
Favorite Websites
Deanship Access Map
Graduate Studies Awards
Deanship's Staff
Staff Directory
Files
Researches
Contact us
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Deanship of Graduate Studies
Document Details
Document Type
:
Thesis
Document Title
:
THE PROPROTEIN CONVERTASE SUBTILISIN/ KEXIN TYPE 9 (PCSK9) GENE R46L VARIANT ASSOCIATION WITH CHANGES IN PLASMA LIPID LEVELS IN SAUDI’S IN JEDDAH AREA
ارتباط طليعة البروتين كونفيرتاز سبتيليزين / كيكسن النوع التاسع و جين R46L البديل مع تغير مستويات الدهون في البلازما في السعوديين في منطقة جدة)
Subject
:
Faculty of Nursing
Document Language
:
Arabic
Abstract
:
Introduction: PCSK9 has a well established role in lipid metabolism. The R46L polymorphism is recognized as loss-of-function (LOF) mutation in the PCSK9 gene. The occurrence of the R46L variant has been studied in different populations and was associated with cardiovascular disease (CVD) protection. However, no study has been conducted to look at the variants in the Saudi population as far. In this study, we estimated the prevalence of the protective variant PCSK9 R46L polymorphism in the Saudi population in Jeddah area and the relationship of the variant with plasma lipid levels (Total cholesterol and LDL-C), major risk factors for CVD. Methodology: A randomly selected cross-sectional samples from the population including 500 apparently healthy Saudi were recruited. The genotyping analysis of PCSK9 R46L (rs11591147) polymorphism was performed using a TaqMan SNP genotyping assay method. Results: We detected two heterozygous (GT) and one homozygous (TT) mutation of the R46L giving the prevalence (0.4% GT, 0.2% TT and 99.4% GG). Carriers of T allele had significantly 17.8% lower total cholesterol (4.43 ± 0.35 vs 5.39 mmol/L ± 0.59), and a 28.3% lower LDL-C (2.63 ± 0.06 vs 3.67 mmol/L ± 0.46) than GG carriers. Conclusion: Even though the LOF variant R46L showed lower prevalence than the western societies, this will translate into greater success in PCSK9 inhibition therapy and LDL reduction. More interesting, this is the first report of LOF variants in PCSK9 in Saudi population. Additional studies will be needed to confirm these findings.
Supervisor
:
Dr. Zuhier A. Awan
Thesis Type
:
Master Thesis
Publishing Year
:
1441 AH
2020 AD
Co-Supervisor
:
Dr. Ghada MA. Ajabnoor
Added Date
:
Thursday, January 16, 2020
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
فوزية عبد العليم بستوي
Bastawi, Fawzia Abdulalim
Researcher
Files
File Name
Type
Description
45766.pdf
pdf
Back To Researches Page